Search | GAKEPS

Dhruv Thapliyal added blog Health
2025-01-14 04:11:51

India Biosimilar Market Size, Growth, Share & Report | 2034
The India biosimilar market size was valued at INR 2.20 billion in 2024, driven by the rising prevalence of chronic diseases across the region. The market is expected to grow at a CAGR of 25.20% during the forecast period of 2025-2034, with the values likely to rise from INR 2.8 billion in 2025 to INR 16.6 billion by 2034. The rapid increase in chronic conditions such as cancer, diabetes,...

0 Comments 0 Shares 5K Views 0 Reviews

Please log in to like, share and comment!
James Smith added blog Health
2025-03-18 05:49:32

Biosimilar Market Overview, Growth Driver, Size, Share & Trends 2024
IMARC Group, a leading market research company, has recently releases report titled “Biosimilar Market Size, Share, Trends and Forecast by Molecule, Indication, Manufacturing Type, and Region, 2025-2033”. The study provides a detailed analysis of the industry, including the global biosimilar market trends, share, size and growth forecast. The report also includes competitor and...

0 Comments 0 Shares 1K Views 0 Reviews

Please log in to like, share and comment!
David Cracc added blog Health
2025-02-24 11:54:39

Emerging Trends in the Trastuzumab Biosimilar Market
Introduction Trastuzumab biosimilars have emerged as cost-effective alternatives to the branded biologic Herceptin, widely used for treating HER2-positive breast and gastric cancers. The increasing adoption of biosimilars due to their affordability and effectiveness is driving the expansion of the Trastuzumab Biosimilar Market. This article explores Trastuzumab Biosimilar Market Size,...

0 Comments 0 Shares 2K Views 0 Reviews

Please log in to like, share and comment!
Dhruv Thapliyal added blog Health
2025-02-04 04:53:11

Europe Biosimilar Market Size, Trend, Share & Outlook | 2034
The Europe biosimilar market reached a value of USD 10.13 Billion in 2024, driven by the extended application of biosimilars in managing various chronic conditions across the region. The market is further expected to grow at a CAGR of 12.80% between 2025-2034 to reach a value of almost USD 33.78 Billion by 2034. Get a Free Sample Report with a Table of...

1

0 Comments 0 Shares 3K Views 0 Reviews

Please log in to like, share and comment!
David Cracc added blog Health
2025-02-18 12:09:01

Global Adalimumab Biosimilar Market: Innovations and Opportunities
Adalimumab, originally marketed under the brand name Humira, is one of the most widely prescribed biologic drugs for the treatment of autoimmune diseases like rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. With Humira approaching its patent expiry in recent years, the Adalimumab biosimilars market has emerged as a significant opportunity for both pharmaceutical...

0 Comments 0 Shares 3K Views 0 Reviews

Please log in to like, share and comment!
David Cracc added blog Health
2025-04-29 16:53:33

Revolutionizing Mucopolysaccharidosis Type I Management: From Enzyme Therapy to Gene Therapy
Mucopolysaccharidosis type I (MPS I) is a rare metabolic disorder caused by a deficiency in the enzyme alpha-L-iduronidase, leading to the accumulation of harmful substances in cells. This condition can lead to severe complications, including developmental delays, heart problems, and joint stiffness. There are three main forms of MPS I: Hurler syndrome, Hurler-Scheie syndrome, and...

0 Comments 0 Shares 937 Views 0 Reviews

Please log in to like, share and comment!